Calprotectin and psoriasin levels were not associated with either telangiectasia or cardiac involvement as an expression of SSc severity (p = 0.382, p = 0.061, and p = 0.083, p = 0.264, respectively) (Supplementary Material Table S4). This evidence concerns the gene S100A7 and telangiectasis.